Cynapsus Thera Cm Sh (CYNA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | CYNA | ORGO | ZVRA | ||
| Company | Cynapsus Thera Cm Sh | Organogenesis Holdings Inc | Zevra Therapeutics Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 40.48 | 4.08 | 9.24 | ||
| High | 40.49 | 4.21 | 9.64 | ||
| Low | 40.47 | 4.01 | 9.15 | ||
| Last | 40.48 | 4.05 | 9.59 | ||
| Change | +0.01 | +0.03 | +0.45 | ||
| % Change | +0.02% | +0.75% | +4.98% | ||
| Volume | 388,800 | 1,173,800 | 678,500 | ||
| 20-Day Average Volume | 139,670 | 751,415 | 709,010 | ||
| Previous Close | 40.47 | 4.02 | 9.13 | ||
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 40.34 | 3.47 | 8.71 | ||
| 20-Day Raw Stochastic | 84.80% | 71.43% | 97.15% | ||
| 20-Day Relative Strength | 90.93% | 63.72% | 64.47% | ||
| Weighted Alpha | +77.10 | +59.93 | +76.65 | ||
| Today's Opinion | N/A | 100% Buy | 100% Buy | ||
| Previous Opinion | N/A | 100% Buy | 100% Buy | ||
| Last Month's Opinion | N/A | 40% Buy | 100% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.07% since 10/13/16 | +4.92% since 11/15/24 | +11.19% since 11/15/24 | ||
| Low | 40.44 on 10/14/16 | 3.76 on 11/18/24 | 8.32 on 11/18/24 | ||
| High | 40.50 on 10/18/16 | 4.21 on 11/22/24 | 9.64 on 11/22/24 | ||
| 1-Month | |||||
| %Chg | +0.70% since 09/20/16 | +30.65% since 10/22/24 | +14.93% since 10/22/24 | ||
| Low | 39.42 on 09/23/16 | 2.75 on 11/04/24 | 7.67 on 10/25/24 | ||
| High | 40.67 on 10/10/16 | 4.57 on 11/13/24 | 9.64 on 11/22/24 | ||
| 3-Month | |||||
| %Chg | +155.23% since 07/20/16 | +47.27% since 08/22/24 | +32.02% since 08/22/24 | ||
| Low | 15.83 on 07/21/16 | 2.45 on 09/06/24 | 6.61 on 10/01/24 | ||
| High | 40.67 on 10/10/16 | 4.57 on 11/13/24 | 9.64 on 11/22/24 | ||
| 6-Month | |||||
| %Chg | +190.39% since 04/20/16 | +43.62% since 05/22/24 | +107.02% since 05/22/24 | ||
| Low | 11.17 on 05/09/16 | 2.28 on 08/12/24 | 4.20 on 07/05/24 | ||
| High | 40.67 on 10/10/16 | 4.57 on 11/13/24 | 9.64 on 11/22/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 532,220 | 536,937 | 511,609 | ||
| Shares Outstanding, K | 13,150 | 132,577 | 53,376 | ||
| Annual Sales | 0 | 433,140,000 | 27,460,000 | ||
| Annual Net Income | -21,530,000 | 4,950,000 | -46,050,000 | ||
| Last Quarter Sales | N/A | 115,180,000 | 3,700,000 | ||
| Last Quarter Net Income | N/A | 12,330,000 | -33,230,000 | ||
| 60-Month Beta | 0.49 | 1.60 | 1.93 | ||
| Per-Share Information | |||||
| Most Recent Earnings | N/A | 0.09 on 11/12/24 | -0.69 on 11/12/24 | ||
| Latest Earnings Date | 11/10/16 | 11/12/24 | 11/12/24 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||